NICU Antibiotics and Outcomes (NANO) Follow-up Study
Public ClinicalTrials.gov record NCT05977400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
NICU Antibiotics and Outcomes Follow-Up Study
Study identification
- NCT ID
- NCT05977400
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sharp HealthCare
- Other
- Enrollment
- 802 participants
Conditions and interventions
Conditions
Interventions
- Ampicillin Drug
- Gentamicin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 23 Weeks to 30 Weeks
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2024
- Primary completion
- Feb 28, 2029
- Completion
- Feb 28, 2029
- Last update posted
- Aug 3, 2023
2024 – 2029
United States locations
- U.S. sites
- 14
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sharp Mary Birch Hospital for Women & Newborns | San Diego | California | 92123 | — |
| Yale University | New Haven | Connecticut | 06511 | — |
| University of South Florida | Tampa | Florida | 33620 | — |
| University of Louisville | Louisville | Kentucky | 40292 | — |
| State University of New York Downstate | Brooklyn | New York | 11203 | — |
| Columbia University | New York | New York | 10027 | — |
| University of Rochester | Rochester | New York | 14611 | — |
| Westchester Medical Center | Valhalla | New York | 10595 | — |
| The Pennsylvania State University | Hershey | Pennsylvania | 17033-0850 | — |
| The Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Jefferson Medical College of Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Magee-Womens Hospital | Pittsburgh | Pennsylvania | 15213 | — |
| The University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05977400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05977400 live on ClinicalTrials.gov.